Fig. 3 (abstract P338).From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)CD8+ T Cell Quantitation in Enoblituzumab-treated ProstatesBack to article page